CorpDev.Org
Daily News for Dealmakers
Big Deal
Suzano Secures Global Tissue Dominance with $3.4 Billion Kimberly-Clark Joint Venture
In a transformative move reshaping the global consumer goods landscape, Brazilian pulp giant Suzano has acquired a 51% stake in Kimberly-Clark’s international tissue business through a $3.4 billion joint venture. This strategic partnership...
Sanofi’s $9.1 Billion Blueprint Acquisition: Strategic Masterstroke in Rare Disease Dominance
Sanofi's landmark $9.1 billion acquisition of Blueprint Medicines marks a pivotal shift in the global biopharma landscape, combining immediate revenue generation with long-term immunology pipeline potential. The deal delivers Ayvakit/Ayvakyt –...
Merck’s Strategic MoonLake Bid: A $3 Billion Hedge Against Keytruda’s Patent Cliff
As Merck & Co. confronts the impending 2028 patent expiration of its $29.5 billion oncology blockbuster Keytruda, the pharmaceutical giant's reported $3 billion pursuit of MoonLake Immunotherapeutics reveals a calculated strategy to dominate...
KKR’s Thames Water Exit: A Watershed Moment for UK Infrastructure Investment
The collapse of KKR's £4 billion rescue bid for Thames Water marks a pivotal juncture in Britain's infrastructure landscape. As bond prices plunge to record lows and regulators impose unprecedented fines, this crisis exposes systemic flaws in...
Toyota’s $33 Billion Privatization Play: Rewiring a Century-Old Keiretsu for the Mobility Era
Deal Rationale: Untangling Japan Inc.'s Web of Cross-Shareholdings Toyota Motor's landmark ¥4.7 trillion ($33B) bid to take Toyota Industries private marks the most aggressive move yet in Japan's corporate governance reform era. The transaction...
Top Jobs Currently Hiring
Thought Leadership
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Strategic Reset: Owens & Minor’s $1.36B Rotech Deal Collapse Reshapes Home Healthcare Landscape
The mutual termination of Owens & Minor's proposed $1.36 billion acquisition of Rotech Healthcare marks a pivotal moment in the home medical equipment sector, exposing regulatory landmines in healthcare M&A while forcing strategic recalibration at...
L’Oréal’s Strategic €1 Billion Play: Acquiring Medik8 to Dominate Clinical Skincare
French beauty conglomerate L'Oréal stands poised to finalize one of 2025's most significant beauty acquisitions with its €1 billion purchase of UK clinical skincare pioneer Medik8 . This transaction - reportedly in exclusive negotiations as of...
Oregon’s SB 951: Reshaping Corporate Influence in Healthcare Through Nation-Leading Legislation
In a landmark move with national implications, Oregon lawmakers passed Senate Bill 951 on May 28, 2025, enacting the most comprehensive state-level restrictions on corporate control of medical practices in U.S. history . This legislative...
Sanofi’s $9.1 Billion Blueprint Acquisition: Strategic Masterstroke in Rare Disease Dominance
Sanofi's landmark $9.1 billion acquisition of Blueprint Medicines marks a pivotal shift in the global biopharma landscape, combining immediate revenue generation with long-term immunology pipeline potential. The deal delivers Ayvakit/Ayvakyt –...
Ascension’s Strategic Pivot: Analyzing the $3.9B AmSurg Acquisition in Outpatient Care’s New Era
As healthcare systems grapple with post-pandemic financial pressures and evolving care delivery models, Ascension Health's potential $3.9 billion acquisition of AmSurg represents a watershed moment in hospital strategy. This transaction – one of...
